ET-1/GM-CSF, IL-4/GM-CSF and ET-1/GM-CSF/IL-4 combination induced a higher α-SMA expression in SSc patients compared to healthy controls (Figure 2B), although no statistical significance could be detected between the subgroups. This evidence concerns the gene IL4 and systemic sclerosis.